NEW YORK, July 15 (GenomeWeb News) - Novation, the supply company for VHA and University HealthSystem Consortium, has signed a three-year agreement to make Bayer Diagnostics' molecular diagnostics products available to the 2,300 hospitals served by the two healthcare alliances.
The pact covers Bayer's Versant bDNA assays for hepatitis C and HIV, Trugene HIV-1 genotyping kits and OpenGene DNA sequencing system. Financial terms of the agreement were not disclosed.
According to a statement released today by Irving, Texas-based Novation, the agreement extends to healthcare organizations that purchase supplies through HealthCare Purchasing Partners International, which markets Novation purchasing pacts to non-members of VHA and UHC.